Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Design Therapeutics, Inc. (DSGN)

15.25   -1.01 (-6.21%) 06-26 22:55
Open: 16.65 Pre. Close: 16.26
High: 16.65 Low: 15.14
Volume: 1,386,218 Market Cap: 851(M)
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function, eventually leading to neurological, cardiac, and metabolic dysfunction; and Myotonic Dystrophy Type-1 (DM1), a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs. It is also developing GeneTAC product candidate portfolio for the treatment of other nucleotide repeat expansion-driven monogenic diseases, such as Fragile X syndrome, spinocerebellar ataxias, amyotrophic lateral sclerosis, frontotemporal dementia, Huntington disease, and spinobulbar muscular atrophy. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 16.66 - 16.74 16.74 - 16.81
Low: 14.96 - 15.04 15.04 - 15.1
Close: 15.12 - 15.26 15.26 - 15.36

Technical analysis

as of: 2022-06-24 4:39:22 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 19.54     One year: 22.82
Support: Support1: 13.26    Support2: 11.11
Resistance: Resistance1: 16.73    Resistance2: 19.54
Pivot: 14.28
Moving Average: MA(5): 15.22     MA(20): 14.05
MA(100): 14.28     MA(250): 15.67
MACD: MACD(12,26): 0.6     Signal(9): 0.4
Stochastic oscillator: %K(14,3): 85.3     %D(3): 85.3
RSI: RSI(14): 58.5
52-week: High: 22.2  Low: 9.6
Average Vol(K): 3-Month: 191 (K)  10-Days: 328 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ DSGN ] has closed below upper band by 23.5%. Bollinger Bands are 9.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sun, 26 Jun 2022
Design Therapeutics (NASDAQ:DSGN) Trading Down 5.7% - Defense World

Tue, 21 Jun 2022
Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth - Yahoo Eurosport UK

Mon, 13 Jun 2022
Design Therapeutics (NASDAQ:DSGN) Trading Down 11.8% - Defense World

Thu, 09 Jun 2022
Design Therapeutics Inc (DSGN) Stock: What Does the Chart Say Thursday? - InvestorsObserver

Thu, 09 Jun 2022
Design Therapeutics (NASDAQ:DSGN) Research Coverage Started at Wedbush - Defense World

Wed, 01 Jun 2022
Design Therapeutics to Present at the 2022 Jefferies Healthcare Conference - KULR-TV

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 56 (M)
Shares Float 18 (M)
% Held by Insiders 36.8 (%)
% Held by Institutions 66.9 (%)
Shares Short 4,060 (K)
Shares Short P.Month 2,890 (K)

Stock Financials

EPS -1
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 7.09
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -10.5
Return on Equity (ttm) -17.1
Qtrly Rev. Growth 0
Gross Profit (p.s.) -0.45
Sales Per Share 0
EBITDA (p.s.) -0.65
Qtrly Earnings Growth 0
Operating Cash Flow -29 (M)
Levered Free Cash Flow -18 (M)

Stock Valuations

PE Ratio -15.41
PEG Ratio 0
Price to Book value 2.15
Price to Sales 0
Price to Cash Flow -28.9

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.